Phase I, healthy, pharmacokinetics,
Showing 26 - 50 of >10,000
Pharmacokinetics Trial in Hong Kong (Atropine sulfate eye drops)
Recruiting
- Pharmacokinetics
- Atropine sulfate eye drops
-
Hong Kong, ChinaHKU Eye Centre
May 2, 2023
Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab
Not yet recruiting
- Healthy Male Subjects
- Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
- Pembrolizumab injection
- (no location specified)
Oct 30, 2023
Healthy Volunteers Trial in Qingdao (SIM0278 Injection/Placebo)
Recruiting
- Healthy Volunteers
- SIM0278 Injection/Placebo
-
Qingdao, China, Shandong, ChinaAffiliated Hospital of Qingdao University
Aug 31, 2023
Healthy Trial in Hangzhou (LPM3480392, Placebo)
Completed
- Healthy
- LPM3480392
- Placebo
-
Hangzhou, Zhejiang, ChinaThe second affiliated hosipital zhejiang university school of me
May 15, 2023
Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)
Not yet recruiting
- Overweight or Obesity
- Xenical® vs EMP 22
- +2 more
-
Uppsala, SwedenCTC Clinical Trial Consultanta AB
Aug 25, 2023
Obstructive Hypertrophic Cardiomyopathy Trial (HRS-1893, Placebo)
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
- HRS-1893
- Placebo
- (no location specified)
May 18, 2023
Healthy Trial in Glendale (Y-2 Sublingual Tablet, Placebo)
Not yet recruiting
- Healthy
- Y-2 Sublingual Tablet
- Placebo
-
Glendale, CaliforniaParexel International Los Angeles Early Phase Clinical Unit
Jul 10, 2023
Healthy Trial (CM326)
Not yet recruiting
- Healthy
- CM326
- (no location specified)
Jan 27, 2023
Healthy Trial (CM310)
Not yet recruiting
- Healthy
- CM310
- (no location specified)
Jan 25, 2023
Healthy Trial in Seoul (JP-1366 20mg tablet, JP-1366 20mg capsule)
Completed
- Healthy
- JP-1366 20mg tablet
- JP-1366 20mg capsule
-
Seoul, Korea, Republic ofYangji Hospital
Apr 17, 2023
Asthma, COPD, Atopic Dermatitis Trial in Beijing (Experimental drug 9MW1911, Placebo)
Active, not recruiting
- Asthma
- +2 more
- Experimental drug 9MW1911
- Placebo
-
Beijing, Beijing, ChinaPeking Union Hospital
Apr 5, 2023
Healthy Volunteers Trial in Zhuhai (TNM002, Placebo)
Completed
- Healthy Volunteers
- TNM002
- Placebo
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital Sun Yat-sen University
Apr 24, 2023
Healthy Trial in Busan (EB-203, Placebo)
Recruiting
- Healthy
- EB-203
- Placebo
-
Busan, Korea, Republic ofBusan Paik Hospital, Inje University
Sep 11, 2022
Healthy Adult Subjects, Pharmacokinetics, Safety and Tolerability Trial in Baltimore (Low dose KT07, High dose KT07, Low dose
Completed
- Healthy Adult Subjects
- +2 more
- Low dose KT07
- +3 more
-
Baltimore, MarylandPharmaron
Oct 13, 2022
Chronic HBV Infection Trial in Chongqing (PA3670)
Recruiting
- Chronic HBV Infection
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
May 6, 2023
Healthy Participants Trial in Hefei (SHEN26 capsule, SHEN26 )
Completed
- Healthy Participants
- SHEN26 capsule
- SHEN26 placebo
-
Hefei, Anhui, ChinaThe Second Hospital of Anhui Medical University
Dec 14, 2022
Heparin-induced Thrombocytopenia Trial in Lincoln (VLX-1005, Argatroban)
Completed
- Heparin-induced Thrombocytopenia
-
Lincoln, NebraskaCelerion, Inc.
Jan 10, 2023
Kidney Transplantation Trial (SHR-2106 injection or )
Not yet recruiting
- Kidney Transplantation
- SHR-2106 injection or placebo
- (no location specified)
Jul 9, 2023
Healthy Trial in Shanghai (SR419 capsules, Placebo)
Completed
- Healthy
- SR419 capsules
- Placebo
-
Shanghai, ChinaShanghai Clinical Research Center Phase I Clinical Research Unit
Aug 2, 2022
Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)
Completed
- Healthy Volunteers
- CMAB007
- Xolair
-
Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 8, 2023
Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)
Completed
- Metastatic Breast Cancer
- Metastatic Gastric Cancer
- Trastuzumab for injection
- Herceptin
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023
Parkinson Disease Trial in Nottingham (NM-101, Placebo)
Not yet recruiting
- Parkinson Disease
- NM-101
- Placebo
-
Nottingham, United KingdomQuotient Sciences
Mar 16, 2023